Extendicare Capex To Depreciation vs Free Cash Flow Yield Analysis
EXE Stock | CAD 10.33 0.03 0.29% |
Extendicare financial indicator trend analysis is much more than just examining Extendicare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Extendicare is a good investment. Please check the relationship between Extendicare Capex To Depreciation and its Free Cash Flow Yield accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Extendicare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Capex To Depreciation vs Free Cash Flow Yield
Capex To Depreciation vs Free Cash Flow Yield Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Extendicare Capex To Depreciation account and Free Cash Flow Yield. At this time, the significance of the direction appears to have pay attention.
The correlation between Extendicare's Capex To Depreciation and Free Cash Flow Yield is -0.84. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Extendicare, assuming nothing else is changed. The correlation between historical values of Extendicare's Capex To Depreciation and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Extendicare are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Capex To Depreciation i.e., Extendicare's Capex To Depreciation and Free Cash Flow Yield go up and down completely randomly.
Correlation Coefficient | -0.84 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most indicators from Extendicare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Extendicare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Extendicare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Extendicare's Discontinued Operations is very stable compared to the past year. As of the 27th of November 2024, Enterprise Value is likely to grow to about 1.6 B, while Selling General Administrative is likely to drop about 53 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 151.7M | 76.8M | 118.4M | 112.5M | Total Revenue | 1.2B | 1.2B | 1.3B | 1.3B |
Extendicare fundamental ratios Correlations
Click cells to compare fundamentals
Extendicare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Extendicare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 888.8M | 963.1M | 900.3M | 781.6M | 672.7M | 1.2B | |
Short Long Term Debt Total | 556.3M | 564.6M | 536.9M | 384.0M | 334.5M | 636.1M | |
Other Current Liab | 9.1M | 23.4M | 16.1M | 7.9M | 6.2M | 5.9M | |
Total Current Liabilities | 275.9M | 279.5M | 281.9M | 275.0M | 226.4M | 294.6M | |
Total Stockholder Equity | 115.4M | 128.2M | 101.9M | 100.7M | 87.9M | 143.7M | |
Property Plant And Equipment Net | 530.5M | 525.9M | 535.6M | 388.7M | 295.9M | 281.1M | |
Net Debt | 459.4M | 384.6M | 432.2M | 216.7M | 259.3M | 246.4M | |
Accounts Payable | 131.4M | 168.0M | 189.1M | 242.2M | 197.1M | 140.6M | |
Non Current Assets Total | 704.9M | 667.0M | 675.4M | 523.5M | 485.6M | 875.3M | |
Non Currrent Assets Other | 71.8M | 37.1M | 32.9M | 30.5M | 35.0M | 33.2M | |
Net Receivables | 66.3M | 73.4M | 83.5M | 64.1M | 91.0M | 127.7M | |
Common Stock Shares Outstanding | 89.1M | 89.8M | 100.9M | 89.0M | 85.0M | 93.4M | |
Liabilities And Stockholders Equity | 888.8M | 963.1M | 900.3M | 781.6M | 672.7M | 1.2B | |
Non Current Liabilities Total | 497.5M | 555.4M | 516.5M | 405.9M | 358.4M | 713.7M | |
Other Current Assets | 20.7M | 40.2M | 26.5M | 24.0M | 20.2M | 19.2M | |
Other Stockholder Equity | 3.7M | 4.9M | 8.2M | 10.6M | 13.1M | 12.4M | |
Total Liab | 773.4M | 834.9M | 798.4M | 680.9M | 584.8M | 1.0B | |
Property Plant And Equipment Gross | 530.5M | 525.9M | 820.0M | 676.6M | 608.8M | 647.3M | |
Total Current Assets | 183.9M | 296.1M | 224.9M | 258.0M | 187.1M | 276.8M | |
Short Term Debt | 133.8M | 71.4M | 73.6M | 19.2M | 19.9M | 18.9M | |
Intangible Assets | 38.2M | 36.5M | 46.6M | 51.2M | 78.5M | 82.4M | |
Retained Earnings | (382.2M) | (371.0M) | (402.5M) | (384.6M) | (393.5M) | (413.1M) | |
Cash | 96.9M | 180.0M | 104.6M | 167.3M | 75.2M | 103.5M | |
Cash And Short Term Investments | 94.5M | 180.0M | 104.6M | 167.3M | 75.9M | 103.6M | |
Accumulated Other Comprehensive Income | (11.3M) | (13.4M) | (11.8M) | (7.8M) | 957K | 1.0M | |
Common Stock Total Equity | 490.9M | 492.1M | 498.1M | 500.6M | 575.7M | 535.5M | |
Common Stock | 498.1M | 500.6M | 500.9M | 475.4M | 467.3M | 534.0M | |
Other Liab | 74.3M | 59.6M | 52.5M | 41.2M | 37.0M | 35.2M | |
Net Tangible Assets | 25.5M | 40.0M | 9.4M | 3.6M | 4.2M | 4.0M | |
Other Assets | 84.5M | 53.0M | 47.3M | 37.8M | 1.0 | 0.95 | |
Long Term Debt | 422.5M | 493.2M | 463.3M | 364.7M | 314.6M | 373.8M | |
Short Long Term Debt | 133.8M | 71.4M | 73.6M | 19.2M | 19.9M | 18.9M | |
Property Plant Equipment | 530.5M | 525.9M | 535.6M | 388.7M | 349.8M | 428.0M | |
Long Term Debt Total | 422.5M | 493.2M | 463.3M | 364.7M | 328.3M | 355.2M | |
Capital Surpluse | 3.7M | 4.9M | 8.2M | 10.6M | 12.2M | 12.8M |
Pair Trading with Extendicare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.Moving together with Extendicare Stock
Moving against Extendicare Stock
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Extendicare Stock
Balance Sheet is a snapshot of the financial position of Extendicare at a specified time, usually calculated after every quarter, six months, or one year. Extendicare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Extendicare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Extendicare currently owns. An asset can also be divided into two categories, current and non-current.